$BMY News Article - Opdivo (nivolumab) Plus Chemot
Post# of 115
(Total Views: 264)
Posted On: 10/07/2020 2:50:54 PM
$BMY News Article - Opdivo (nivolumab) Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial https://marketwirenews.com/news-releases/opdi...71382.html
(0)
(0)Bristol-Myers Squibb Company (BMY) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼